-
Medherant Appoints Sheryl Caswell to Lead Clinical Development of Products Based on its Revolutionary TEPI Patch®
Coventry, UK, 6th June 2017 / Sciad Newswire / Medherant Ltd, a University of Warwick spin-out company developing a novel transdermal drug delivery patch technology, is pleased to announce the appointment of Sheryl Caswell as Head of Clinical Development. Sheryl joins Medherant as the Company prepares to start clinical studies with its first product, an ibuprofen patch…
-
Automotive, aerospace, materials – first to benefit from graphene, says new report
A new report predicts that the automotive, aerospace and materials industries will make strong gains from graphene within a 5-10-year time-frame.
-
Future Food-Tech New York Returns June 7th – 8th
Food. Essential for survival, a crucial element of social interaction, and an irreplaceable source of enjoyment. But how to secure its supply and quality for the future? The return of Future Food-Tech to New York, June 7-8, provides the opportunity for investors, start-ups, technology companies and food and ingredients manufacturers to gather and discuss this any many…
-
What Role Can Restaurants Play in Exposing Consumers to New Food Technology and Ingredients Innovation?
A Conversation with Brad Farmerie of Saxon + Parole and David Lee from Impossible Foods. New York, USA, 18th May 2017 / Sciad Newswire / With limitless options on where to eat and what food to buy, today’s New Yorkers are hunting down foods which meet their personal dietary requirements and health goals, are sustainably sourced, and quench their…
-
Domainex Signs Multi-Year Agreement with Dotmatics to Streamline Its Integrated Drug Discovery Services
New, fully integrated systems to include data reporting and visualization, reproduction of assay workflows, ELN and registration tools Bishop’s Shortford, UK, 17th May 2017 / Sciad Newswire / Dotmatics, a leading provider of scientific informatics solutions and services to the life sciences industry, today announces that Domainex, a small-molecule therapeutics company that provides integrated drug research services to global pharmaceutical,…
-
Orthonika accelerates development of total meniscus replacement and secures additional funding
Orthonika Limited, is pleased to announce success in securing funding for development of its novel synthetic total knee meniscus replacement.
-
Two new start-up plans win BrisSynBio’s first synthetic biology entrepreneurship competition
London, UK, 11th May 2017 / Sciad Newswire / Two start-ups’ proposals have been chosen as the winners of the first competition to discover and accelerate new synthetic biology companies at the University of Bristol. The competition was run as part of a growing partnership between the University of Bristol’s Centre for Synthetic Biology (BrisSynBio) and SynbiCITE, the UK’s national…
-
Medherant Appoints Laboratoires Plasto Santé as Transdermal Drug Delivery Patch Manufacturer
Coventry, UK, 8th May 2017 / Sciad Newswire / Medherant Ltd, a University of Warwick spin-out company developing a novel transdermal drug delivery patch technology, has appointed Laboratoires Plasto Santé to manufacture its first drug delivery patches. The first batch of patches, based on Medherant’s proprietary TEPI Patch® technology, will be used for clinical studies of the…
-
New survey suggests that 9 out of 10 patients on warfarin would find self-monitoring an easy and quick way to monitor their health
London, UK, 2nd May 2017 / Sciad Newswire / Roche Diagnostics UK and Ireland launches the next generation of INR patient self-monitoring meter for patients on warfarin anticoagulant therapy. The new CoaguChek INRange meter allows patients to send their results to their clinic via an App on their phone using wireless connectivity. This innovation helps to empower patients to…
-
Latest work from top UK cancer researchers could hold potential for ‘game-changing’ treatments for rare bile duct cancer
Stansted, UK, 24th April 2017 / Sciad Newswire / The incidence of bile duct cancer (cholangiocarcinoma) is increasing year on year throughout the world. More than 2,500 people will be diagnosed with this cancer in the UK in the next year and for most this will be a lethal diagnosis. Fewer than 5% will survive for 12 months –…